About Orbicular Pharmaceutical Technologies Private Limited
Data last updated:
Orbicular Pharmaceutical Technologies Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 13 August 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2008PTC060606. Its GSTIN is 36AABCO1181G1ZO (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹11.18 Cr. It is led by directors including Sivaraman Mohan Mailatur (Managing Director) and Hiren Dasharathbhai Patel.
Its last annual general meeting (AGM) was held on 12 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P.No 53 Aleap Industrial Estate Gajularamaram Behind Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500090.
As per the financials filed for FY 2025, the company reported a revenue of ₹272.04 Cr, a growth of 41% compared to the previous year. For the same year it recorded a net profit of ₹28.36 Cr (net margin 10.4%) and EBITDA of ₹96.66 Cr (EBITDA margin 35.5%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years.
The company has about 253 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Orbicular Pharmaceutical Technologies. As per MCA filings, the company has open charges of ₹449.05 Cr and satisfied charges of ₹15.7 Cr on record. Court records list 1 case involving the company, including 1 filed against it. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹151.01 Cr; the latest was in May 2024.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website orbicular.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressP.No 53 Aleap Industrial Estate Gajularamaram Behind Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500090
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Orbicular Pharmaceutical Technologies Private Limited
The main business activity of Orbicular Pharmaceutical Technologies is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Orbicular Pharmaceutical Technologies Private Limited FY 2025 filings available
Orbicular Pharmaceutical Technologies Private Limited reported revenue of ₹272.04 Cr (up 41% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Orbicular Pharmaceutical Technologies Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 6% over three years, including 41% growth in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Orbicular Pharmaceutical Technologies Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹96.66 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹28.36 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Orbicular Pharmaceutical Technologies Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 35.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Orbicular Pharmaceutical Technologies are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited is audited by MN Reddy & Co for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MN Reddy & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hiren Dasharathbhai Patel | Director | 24 Aug 2012 | 14 Years 1 Months | Current |
| Sivaraman Mohan Mailatur | Managing Director | 06 Aug 2010 | 16 Years 2 Months | Current |
| Meena Mohan | Director | 13 Aug 2008 | 18 Years 1 Months | Current |
| Rahul Gawande Sudhakar | Director | 01 Jul 2019 | 7 Years 3 Months | Current |
| Bhaveshkumar Vallabhbhai Patel Also directs: Invitron Advanced Analytics Private Limited | Director | 01 Apr 2022 | 4 Years 6 Months | Current |
| Visalakshi Chandramouli Also directs: Sakar Healthcare Limited, Brinton Pharmaceuticals Limited, Linux Laboratories Private Limited and 4 more | Nominee Director | 31 May 2024 | 2 Years 4 Months | Current |
Ownership and Shareholding of Orbicular Pharmaceutical Technologies Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Orbicular Pharmaceutical Technologies Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2025 | Hdfc Bank Limited | ₹40 Cr | Open |
| 24 Nov 2025 | Hdfc Bank Limited | ₹60 Cr | Open |
| 30 Oct 2025 | Others | ₹8 Cr | Open |
| 28 Jun 2025 | Others | ₹4.5 Cr | Open |
| 28 Jun 2025 | Others | ₹23 Cr | Open |
Total charge records: 19 View all charges
Deals & Funding of Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹151.01 Cr; the latest was in May 2024.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2024 | Funding round | ₹150 Cr | Investors: Tata Capital Healthcare Fund |
| Dec 2023 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Sep 2022 | Secondary share transfer | Undisclosed | Seller: 4 individuals |
| Nov 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Sep 2016 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
Full deal history
All 6 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Petition | Filed against the company by Teva Pharmaceuticals International | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies operates one associated brand: Orbicular Pharmaceutical Technologies. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of niche generic and specialty pharmaceutical products | orbicular.co.in |
Employees and EPFO Compliance at Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited has a workforce of 253 employees as of Dec 11, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Invitron Advanced Analytics Private Limited | U73100TG2013PTC087372 | Locked |
Showing major subsidiaries. Total: 1.
CIN History of Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies has one previous CIN (Corporate Identification Number): U24233AP2008PTC060606. The current CIN is U24233TG2008PTC060606, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2008PTC060606 | Current |
| U24233AP2008PTC060606 | Previous |
News related to Orbicular Pharmaceutical Technologies Private Limited
Recent Activity on Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies Private Limited has 11 board changes on record since 2008: 6 appointments and 5 cessations. The latest: Visalakshi Chandramouli was appointed as Nominee Director on 31 May 2024.
32 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Orbicular Pharmaceutical Technologies Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Orbicular Pharmaceutical Technologies Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Orbicular Pharmaceutical Technologies Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCO1181G1ZO | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Orbicular Pharmaceutical Technologies Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orbicular Pharmaceutical Technologies Private Limited
Orbicular Pharmaceutical Technologies is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 13 August 2008 (18+ years old) and is registered under CIN U24233TG2008PTC060606.
Orbicular Pharmaceutical Technologies reported revenue of ₹272.04 Cr for FY 2025 (up 41% YoY).
Orbicular Pharmaceutical Technologies has 6 current directors:
- Sivaraman Mohan Mailatur - Managing Director
- Hiren Dasharathbhai Patel - Director
- Meena Mohan - Director
- Rahul Gawande Sudhakar - Director
- Bhaveshkumar Vallabhbhai Patel - Director
- Visalakshi Chandramouli - Nominee Director
Orbicular Pharmaceutical Technologies reported a net profit of ₹28.36 Cr (net margin 10.4%) and EBITDA of ₹96.66 Cr (EBITDA margin 35.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Orbicular Pharmaceutical Technologies is 6% over three years. In the latest year (FY 2025) revenue rose 41%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Orbicular Pharmaceutical Technologies is 36AABCO1181G1ZO, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Orbicular Pharmaceutical Technologies is U24233TG2008PTC060606. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orbicular Pharmaceutical Technologies has 1 court case on record: 1 filed against it.
Orbicular Pharmaceutical Technologies was incorporated on 13 August 2008, making it 18+ years old. It is registered with the Registrar of Companies, Hyderabad.
Orbicular Pharmaceutical Technologies has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹151.01 Cr; the latest was in May 2024.